Sysmex Europe
Menu

HISCL SARS-CoV-2 S-IgG Assay Kit

Quantification of SARS-CoV-2 S-IgG antibodies

The HISCL SARS-CoV-2 S-IgG Assay Kit for HISCL-5000 aims to help healthcare providers in monitoring and analysing temporal immunological profiles of SARS-CoV-2 infection and SARS-CoV-2 vaccine effectiveness in different population groups and areas.

More details

The assay targets IgG antibodies against the receptor-binding domain (RBD) portion situated in the S1 domain of the SARS-CoV-2 spike protein (S-protein), which play an important role in the neutralisation activity of the virus* (see figure).

 

Excellent clinical performance

The assay has a clinical sensitivity of 100% (≥ 21 days post onset of symptoms in 99 COVID patients) and a clinical specificity of 99.8% (477 samples from healthy individuals collected before the COVID-19 pandemic started), proving it to be accurate, reliable and of high clinical performance.

Sensitivity:

Days post onset of symptoms Total number Number of positive results Number of negative results PPA
(95% C.I.)
≥ 21 99 99 0 100%
(96.3 – 100)

 

Specificity:

  Total number Number of positive results Number of negative results NPA
(95% C.I.)
Pre-COVID-19 477 1 476 99.8%
(98.8 – 100)

 

Requirements
The HISCL SARS-CoV-2 S-IgG Assay Kit is to be used on the HISCL-5000 fully automated, random-access immunochemistry analyser. Reagents needed to perform the test:

Reagent name Item number Package size
HISCL SARS-CoV-2 S-IgG Assay Kit AP682349 100 tests
HISCL SARS-CoV-2 S-IgG Calibrator AR235730 5 vials (1 x each levels 1, 2, 3, 4 and 5) x 1 mL (4–5 tests per vial)
HISCL SARS-CoV-2 S-IgG Control CZ361947 6 vials (2 x each levels 1, 2 and 3) x 3 mL (12–15 tests per vial)
HISCL Diluent CJ667474 100 tests

 

*Sources:

Noda K, Matsuda K, Yagishita S et al (2021): A novel highly quantitative and reproducible assay for the detection of anti-SARS-CoV-2 IgG and IgM antibodies. Sci Rep 11, 5198.

Mazzini et al (2021): Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples. Journal of Immunological Methods, Volume 489, article no. 112937, ISSN 0022-1759.

Technical specifications
Analyte S-IgG antibodies to SARS-CoV-2
Test technology chemiluminescence enzyme immunoassay (CLEIA)
Dedicated instrument automated immunoassay system HISCL-5000
Throughput 200 tests/h on the HISCL-5000
Time to result 17 minutes to the first result on the HISCL-5000
Sample type serum / plasma
Sample volume 10–30 µL
Expression of results BAU/mL quantitative (calibrated against WHO international reference standard)
Cut-off value 20 BAU/mL
Measurement tubes conical 4-mL sample cup (no barcode possible) or standard sample tube
(13–16 mm diameter, 75–100 mm height) with the option of barcode labelling

 

Contact

Sysmex Europe GmbH

Bornbarch 1

22848 Norderstedt

Germany

+49 (40) 527 26 0

+49 (40) 527 26 100

Explore more

Copyright © Sysmex Europe GmbH. All rights reserved.
Customize your experience

We use cookies to enable you to optimally use our Website and to improve our communication with you. We shall take your selection into account and use only the data for which you give us your consent.

* May lead to restrictions in content and in the user experience
Detail about cookies
Essential cookies
These cookies help to make our website usable by enabling basic features such as page navigation and access to secure areas of our website. Our website cannot function properly without these cookies.
Statistics cookies
By collecting information anonymously, these cookies help us to understand how visitors interact with our website. This information enables us to continually improve our platform.
Marketing cookies
are used to track visitors on websites. The intention is to show advertisements that are relevant and appealing to the individual user and are, therefore, valuable to publishers and third-party advertisers.